Des Jarlais DC, Galea, S, Tracy, M, Tross S, Vlahov, D. Stigmatization of Newly Emerging Infectious Diseases: AIDS and SARS . Am J Public Health. 2006; 96(3):561-7. Available
John W. Ward and Christian Warren
New York: Oxford University Press, 2006.
Available
Behar E, Chin JJ
New York: Division of Health Policy, New York Academy of Medicine, 2006.
Bower WA, Culver DH, Castor D, Wu Y, James VN, Zheng H, Hammer S, Kuhnert WL, Williams IT, Bell BP, Vlahov D, Dezzutti CS. Changes in Hepatitis C Virus (HCV) Viral Load And Interferon-Alpha Levels in HIV/HCV-Coinfected Patients Treated With Hight Active Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2006; Available
2005 Publications
Mitchell CS, Gershon RR, Lears MK, Vlahov D, Felknor S, Lubelczyk RA, Sherman MF, Comstock GW. Risk of tuberculosis in correctional health care workers. J Occup Environ Med. 2005; 47(6):580-586. Available
Howe CJ, Fuller CM, Ompad DC, Galea S, Koblin B, Thomas D, Vlahov D. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend. 2005; 79(3):389-395. Available
Rusch ML, Farzadegan H, Tarwater PM, Safaeian M, Vlahov D, Strathdee S. Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy. AIDS Behav. 2005; 1-11.
Howe CJ, Fuller CM, Ompad DC, Galea S, Koblin B, Thomas D, Vlahov D. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend. 2005; 79(3):389-95. Available
Macalino GE, Vlahov D, Dickinson BP, Schwartzapfel B, Rich JD. Community incidence of hepatitis B and C among reincarcerated women. Clin Infect Dis. 2005; 41(7):998-1002. Available
Gershon RR, Mitchell C, Sherman MF, Vlahov D, Lears MK, Felknor S, Lubelczyk RA. Hepatitis B vaccination in correctional health care workers. Am J Infect Control. 2005; 33(9):510-18.
Fuller CM, Absalon J, Ompad D, Nash D, Koblin B, Blaney S, Galea S, Vlahov D. A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000-2003. J Urban Health. 2005; 82(1) Suppl.1:151-161. Available
2004 Publications
Garten RJ, Lai S, Zhange J, Liu W, Chen J, Vlahov D, Yu XF. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. International Journal of Epidemiology. 2004; 33(1):182-8. Available
Karacki PS, Gao X, Thio CL, Thomas DL, Goedert JJ, Vlahov D, Kaslow RA, Strathdee S, Hilgartner MW, O'Brien SJ, Carrington M. MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes and Immunity. 2004; 5(4):261-6.
Thio CL, Goedert JJ, Mosbruger T, Vlahov D, Strathdee SA, O'Brein S, Astemborski J, Thomas DL. An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes and Immunity. 2004; 5(4):294-300.
Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. American Journal of Public Health. 2004; 94(7):1218-23. Available
Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R. SARS control and psychological effects of quarantine, Toronto, Canada. Emerging Infectious Diseases. 2004; 10(7):1206-12.
Available
Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astermborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004; 305(5685):872-4. Available
Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. Journal of Infectious Diseases. 2004; 190(6):1046-54. Available
2003 Publications
Latka M. Drug-using women need comprehensive sexual risk reduction interventions. Clin Infect Dis. 2003; 37(Suppl 5):S445-S450. Available
Bernstein KT, Jacobson LP, Jenkins FJ, Vlahov D, Armenian HK. Human herpes virus type 8 (HHV-8) seroprevalence and factors associated with infection in an injecting drug user cohort. Sexually Transmitted Diseases. 2003; 30(3):199-204. Available
Roehrig J, Nash D, Maldin B, Labowitz A, Martin DA, Lanciotti RS, Campbell GL. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerging Infectious Diseases. 2003; 9(3):376-9. Available
Check-Modi WS, O'Brien TR, Vlahov D, Buchbinder S, Gomperts E, Phair J, O'Brien SJ, Winkler C. Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression. Immunogenetics. 2003; 55(3):157-164.
Check-Modi WS, O'Brien TR, Vlahov D, Buchbinder S, Gomperts E, Phair J, O'Brien SJ, Winkler C. Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression. Immunogenetics. 2003; 55(3):157-64.
An P, Vlahov D, Margolick JB, Phair J, O'Brien TR, Lautenberger J, O'Brien SJ, Winkler CA. A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+T cell depletion in human immunodeficiency virus-1-infected individuals. Journal of Infectious Diseases. 2003; 188(2):228-31. Available
Koblin B, Factor SH, Wu Y, Vlahov D. Hepatitis C virus infection among non-injecting drug users in New York City. Journal of Medical Virology. 2003; 70(3):387-90.
Tesoriero J, French T, Weiss L, Waters M, Finkelstein R. Stability of adherence to highly active antiretroviral therapy over time amoung clients enrolled in the treatment adherence domonstration project. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2003; 33(4):484-93. Available
Tun W, Celentano D, Vlahov D, Strathdee S. Attitudes toward HIV treatments influence unsafe sexual and injection practices amoung injecting drug users. AIDS. 2003; 17(13):1953-62. Available
Zwahlen M, Vlahov D. Commentary: modeling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users. International Journal of Epidemiology. 2003; 32(5):715-6. Available
Royal W, Vlahov D, Lyles C, Gajewski CD. Retinoids and drugs of abuse: implications for neurological disease risk in Human Immunodeficiency Virus type 1 infection. Clinical Infectious Diseases. 2003; 37 Suppl 5:S427-32. Available
2002 Publications
Wilson L,...Vlahov D.. Prospective study of infective endocarditis among injection drug users. Journal of Infectious Diseases. 2002; 185(12):1761-6. Available
2001 Publications
Latka M, Ahern J... Vlahov D.. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. Journal of Substance Abuse. 2001; 13(1-2):73-88.
Riley ED,...Vlahov D. Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors. American Journal of Respiratory and Critical Care Medicine. 2001; 164(1):82-5. Available
2000 Publications
Factor SH, Whitney CG, Zywicki SS, Schuchat A. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstetetrics and Gynecology. 2000; 95(3):377-82. Available
1999 Publications
Gershon RR, Karkashian CD, Vlahov D, et al. Compliance with universal precautions in correctional health care facilities. Journal of Occupational and Environmental Medicine. 1999; 41(3):181-9. Available
Kimura M,... Vlahov D, et al. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. Journal of Infectious Diseases. 1999; 179(5):1297-300. Available
Note: Bibliographic citations are received directly from the authors and may not reflect the exact citations of the actual published works.
